Tingo Medical
Project: Inserted CGM with a phone app
An implication is the founders intend to combine a future iCGM with the FDA-cleared Triple Jump pump. → offer the combo to Medtronic for $500M?
Co-Founders:
Lior Shtram CEO
Guy Shinar
James Shapiro
Ofer Yodfat (former CTO Medingo → Roche)
Investors
● Grove Ventures (~ $500M fund)
IP
|
WO-2022044017-A1 |
Continuous glucose
sensor and mounting assembly |
Tingo Medical Ltd. |
Lior STRAM, Ofer
Yodfat |
|
WO-2024231921-A1 |
Bio-electrochemical sensors |
Tingo Medical Ltd. |
Guy Shinar, Lior Shtram, Yehonatan RAVENNA, Idan GAL,
Marina BASOVICH, Ofer Yodfat |
|
WO-2024231921-A1 |
Capteurs bio-électrochimiques |
Tingo Medical Ltd. |
Guy Shinar, Lior Shtram, Yehonatan RAVENNA, Idan GAL,
Marina BASOVICH, Ofer Yodfat |
Notes:
● Triple Jump (ACE pump) + Tingo (CGM -> iCGM?) = HCL system
● Triple Jump is FDA-cleared as an ACE pump
● In 2021 Tingo was recruiting a physicist/mathematician — suspect they were working on a multivariate approach to enhance performance
● 3 very recent 2024 published patent apps with a lot of detail, looks similar to Dexcom — not trying to delay publication
● Isssued Abbott and Dexcom portfolios are formidable
● Shared (Tingo/Medingo) RA person
● No clinical registered -implies an FDA submission no sooner than about 2028
● If an influx of about $100M - $200M the project could be serious